Banner Image

Test Directory

Paraneoplastic Antibody Evaluation with Reflex to Titer and Line Blot, Basic

Test Summary

Detection of antineuronal autoantibodies aids the diagnosis of paraneoplastic syndromes and autoimmune encephalopathies and related conditions. Identification of specific antineuronal autoantibodies may direct evaluation for underlying often occult malignancy. Characterization of autoantibody specificity may allow syndromic classification and assist in diagnosis and management. Antineuronal antibodies are detected and characterized based on indirect immunofluorescence staining pattern on multiple neuronal, non-neuronal tissues, and transformed substrate cells, and radioimmunoassay's, and western blot analysis.

Aliases

  • N/A

Specimen Collection

Special Instructions

N/A

Preferred Specimen

6 mL frozen serum

Minimum Volume

3 mL

Instructions

N/A

Patient Preparation

N/A

Storage

Transport tube

Transport Temperature

Frozen

Specimen Stability

  • Room temperature: 48 hours
  • Refrigerated: 48 hours
  • Frozen 21 days

Limitations

N/A

Other Acceptable Specimens

N/A

Unacceptable Specimens

Gross hemolysis • Grossly lipemic • Grossly icteric

Order Code

PARNEO

EPIC (Premier) Code

LAB6456

Includes

If Paraneoplastic Antibody Screen, IFA, Basic is positive for ANNA3, then ANNA-3 Ab, IFA Titer will be performed at an additional charge (CPT code(s) 86256).
If Paraneoplastic Antibody Screen, IFA, Basic is positive for PCA-2, then PCA-2 Ab, IFA Titer will be performed at an additional charge (CPT code(s) 86256).
If Paraneoplastic Antibody Screen, IFA, Basic suggests NMO-5-IgG, then specific CBA-IFA assay will be performed at an additional charge (CPT code(s) 86255).
If Paraneoplastic Antibody Screen, IFA, Basic suggests AMPA-R, GABA-B-R, or NMDA-R, then specific CBA-IFA assay will be performed at an additional charge (CPT code(s) 86255 x4).
If Paraneoplastic Antibody Screen, IFA, Basic is positive or indeterminate, then Paraneoplastic Antibody, LB, Basic will be performed at an additional charge (CPT code(s) 84182 x5, 86341).
If Anti-Striated Muscle Antibody Screen is positive, then Anti-Striated Muscle Antibody Titer will be performed at an additional charge (CPT code(s) 86256).
If AChR Binding Antibody is positive (≥0.50) or Equivocal (0.31-0.49), then Paraneoplastic Antibody, LB, Basic and AChR Modulating Antibody will both be performed at additional charges (CPT code(s) 83519).

CPT Code

  • 86255 (x10)
  • 83519 (x3)
  • 86596 (x2)

Billing Code

  • 670965
  • 670966
  • 670967

CPT Statement

Methodology

See individual tests

FDA Status

This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Physician Attestation of Informed Consent

N/A

Testing Laboratory

Quest Diagnostics Nichols Institute
33608 Ortega Highway
San Juan Capistrano CA, 92675

Department

Reference Testing

Reference Range

See Laboratory Report

Setup Schedule / Expected Turnaround Time

Varies; Report available: 4 - 13 days

Specimen Collection

Special Instructions

N/A

Preferred Specimen

6 mL frozen serum

Minimum Volume

3 mL

Instructions

N/A

Patient Preparation

N/A

Storage

Transport tube

Transport Temperature

Frozen

Specimen Stability

  • Room temperature: 48 hours
  • Refrigerated: 48 hours
  • Frozen 21 days

Limitations

N/A

Other Acceptable Specimens

N/A

Unacceptable Specimens

Gross hemolysis • Grossly lipemic • Grossly icteric

Billing

CPT Code

  • 86255 (x10)
  • 83519 (x3)
  • 86596 (x2)

Billing Code

  • 670965
  • 670966
  • 670967

CPT Statement

Result Information

Methodology

See individual tests

Testing Laboratory

N/A

Reference Range

See Laboratory Report

Setup Schedule / Expected Turnaround Time

Varies; Report available: 4 - 13 days